Quantcast
Last updated on April 17, 2014 at 13:22 EDT

Global Biotech and Pharmaceutical Conference Early Bird Registration Discounts End This Week

September 12, 2012

FARMINGTON, Conn., Sept. 12, 2012 /PRNewswire-iReach/ — Bio-IT World Expo Europe 2012 October 9-11, 2012 – Vienna, Austria

(Photo: http://photos.prnewswire.com/prnh/20120912/CG73074)

The Fourth Annual Bio-IT World Europe Conference & Expo attracts life sciences, pharmaceutical, informatics and IT professionals from across Europe and the rest of the world. This year’s conference will feature four tracks: Clinical Genomics; Data Infrastructure and High Performance Computing; Drug Discovery Informatics to Personalized Therapeutics; and Cloud-Based Bioinformatics. A unique opportunity to share research advances, information trends and new enabling technologies that are driving biomedical research and drug development.

Keynote speakers are to include Yike Guo, Ph.D., Professor of Computing Science at Imperial College London; Ian Dix, Ph.D., Director of Analytics, Information and Knowledge Engineering (AIKE), and R&D Information at AstraZeneca; Paul Flicek, Ph.D., Principal Investigator & Head of Vertebrate Genomics Team, EMBL-European Bioinformatics Institute; Hermann Hauser, Entrepreneur and Partner at Amadeus Capital Partners; Eric D. Perakslis, Ph.D., CIO and Chief Scientist of Informatics at the U.S. Food and Drug Administration (FDA); Alison Davis, Director of Information Management at the Medicines and Healthcare Products Regulatory Agency (MHRA); and Luc Verhelst, CIO at the European Medicines Agency (EMA).

Early bird discounts expire this week, register through GII to save nearly $200 before September 14 at http://www.giiconference.com/chi229590-2012/

PK/PD of Novel Constructs
October 10 – 12, 2012 – Bethesda, MD, USA

Understanding the activity of novel constructs in animal models and clinical studies is critical to their success. There are numerous constructs of bispecific and multiclonal antibodies, antibody-drug conjugates, and antibody fragments heading to the clinic that are diverse in nature. This conference will delve into tools for understanding effects in humans and engineering for optimal efficacy, safety and metabolism, and strive to uncover the link between immunogenicity and pK/pD.

Keynote speakers are to include Louis M. Weiner, M.D., Director, Lombardi Comprehensive Cancer Center; Professor and Chair, Department of Oncology, Georgetown University Medical Center; Joseph P. Balthasar, Ph.D., Professor, Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, SUNY Buffalo; and Vibha Jawa, Ph.D., Principal Scientist, Clinical Immunology, Amgen

Early bird discounts expire this week, register through GII to save $200 before September 14 at http://www.giiconference.com/chi240526-2012/

Immunogenicity Summit 2012
10-12 October 2012 – Bethesda, MD, USA

The Leading Summit Connecting Industry, Academia and Regulators on Immunogenicity Testing, Immunogenicity Avoidance and Regulatory Guidance

Following year-on-year success, CHI presents their fourth Immunogenicity Summit. We will continue to provide strong interaction and discussion with the regulatory authorities (40 FDA representatives in 2011), updates on immunogenicity testing strategies and means of controlling immunogenicity. New this year will be a focus on characterization and impact of immune complexes, in vivo assessment with immune tolerant mice, and anti-idiotype assays for hypersensitivity. Last year’s attendance was up by 20% with over 250 attendees representing over 50 global organizations.

Keynote & featured Speakers are to include: Steve J. Swanson, Ph.D., Director, Medical Sciences, Clinical Immunology, Amgen; Amy Rosenberg, M.D., Director, Therapeutic Proteins, CDER/FDA; Susan Kirshner, Ph.D., Associate Chief, Laboratory of Immunology, Therapeutic Proteins, Biotechnology, CDER/FDA; Daniela Verthelyi, M.D., Ph.D., Chief, Immunology, Therapeutics Proteins, CDER/FDA; Jack Ragheb, M.D., Ph.D., Principal Investigator, Immunology, Therapeutic Proteins, CDER/FDA; Paul Chamberlain, NDA Advisory Board; Roy Jefferis, Ph.D., C.Chem, FRSC, MRCP, FRCPath, D.S., Professor Emeritus, School of Immunity & Infection, University of Birmingham UK; and Valerie Quarmby, Ph.D., Director and Principal Scientist, BioAnalytical Sciences, Genentech, Inc.

Early bird discounts expire this week, register through GII to save nearly $200 before September 14 at http://www.giiconference.com/chi240525-2012/

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Information, Inc.


Source: PR Newswire